Cogent Biosciences

Executive Assistant

• Provide administrative support to the Commercial team (CCO and other VP+ executives)
• Calendar management, scheduling meetings, and ensuring appropriate time management (schedules prep time for important meetings, time to read emails, etc.)
• Coordinate extensive business travel and understand travel/business etiquette
• Manage expense reporting and prepare/submit complex expense reports
• Coordinate leadership team meetings – set agenda, attend, capture meeting minutes and follow through on action items
• Contract management and manage contracts with Cogent Legal and third-party vendors, ensuring compliance and timely execution
• Track and coordinate departmental initiatives and projects by driving timelines as appropriate
• Coordinate communications across departments (field staff, etc.) and direct field personnel to appropriate contacts or resources
• Logistics support - coordination and set up of meetings, events, off sites; arrange location, equipment, prepare agenda, take minutes
• Consolidate, edit and proofread PPT presentations and documents as needed
• Utilize internal systems to process invoices
• Some support may be needed outside of office hours
• This is an onsite role with some WFH flexibility depending on business needs

Manager

• Lead strategic and tactical execution of key scientific congresses (US and globally) supporting the launch of bezuclastinib across three indications.
• Develop and implement a centralized congress strategy aligned with brand and franchise imperatives.
• Lead annual congress planning cycles including sponsorship decisions, booth presence, onsite events, and omnichannel integration.
• Partner with Medical Affairs, Marketing, Sales, and Compliance to ensure cohesive and compliant congress execution.
• Oversee Tier 1 congresses across priority therapeutic areas and ensure high-quality delivery of all touchpoints.
• Serve as Project Owner for congress assets (e.g., booth schematics, pre-conference decks) and manage internal review/approval processes.
• Manage external vendors and agencies to deliver congress experiences on time and within budget.
• Facilitate alignment across medical strategy, field teams, communications, and sponsorships.
• Lead work streams to assess and evolve congress capabilities, vendor partnerships, and ways of working.
• Own congress budget forecasting, PO management, accruals, and financial reporting.
• Develop and implement congress performance measurement frameworks and share insights to optimize future investments.

Senior Manager, Commercial Congress Strategy and Execution

Operations

• Strategic partner to Senior Sales Leadership, Market Access, Marketing, Patient Services and Analytics to understand key functional needs that translate to field operational solutions and execution.
• Engage and Align with critical cross-functional team members that support field teams (IT, HR, Compliance, Sales Training, Congress Execution, Medical, etc).
• Key field operations leader for real-time issue resolution, solution development, performance monitoring and operational support needs.
• Develop and lead all the field planning processes (at the National and Regional level) required to enable a field force to launch in the rare disease and oncology space.
• Develop and lead the annual cadence of key field engagements and meetings (business reviews, key sales meetings, performance updates, etc).
• Develop key field performance management and monitoring systems, processes and reporting (goals, key performance and execution metrics, etc) that are strategically aligned and visible to all stakeholders.
• Ensure compliance with regulatory and legal requirements, including credentialing and spend reporting.
• Collaborate with key functions (IT, L&D, Marketing) to develop, integrate and implement key field-facing tools such as CRM, call/business planning tools, peripherals (such as tablets), virtual selling capabilities, etc.
• Lead the onboarding and ongoing training requirements for the field to adopt new technology and processes into their way of working.
• Develop/implement novel enabling SOPs for the field force to allow them to perform more effectively.
• Find opportunities to leverage technology or new digital solutions to improve productivity, simplicity and engagement of the field team.
• Oversee vendor relationships related to CRM, data analytics, and field operations platforms.
• Develop scalable reporting capabilities, field-facing dashboards, KPIs, and scorecards that enable actionable insights, performance monitoring and support coaching conversations.
• Work with commercial leadership to establish the overarching philosophy of the SIP (sales incentive plan) and build the SIP integration plan for the field (quota setting process, key data sources and inputs, sales vs quota reporting capabilities, payout frequency and processes, QA/QC processes).
• Build field response process and capability to respond to data, IC, and comp enquiries.
• Work with senior leadership and external partners to design a fit for purpose customer facing organization with the right capabilities to ensure a best-in-class launch.
• Optimize the deployment of field resources and geographies aligned with the market opportunities across Cogent’s three potential indications, HCP targeting, key centers of excellence in each territory.
• Support the scale and build of the field operations resourcing and infrastructure to prepare for launch.
• Act as a key member of the Launch Readiness workstream to represent the field readiness and key milestones reflecting the preparations for field activation on Day 1.

Senior Director, Field Operations

Director

• Act as the key strategic advisor to senior commercial leadership on ensuring the executional readiness and continuous improvement of the commercial organization to effectively launch Cogent Biosciences’ first product, bezuclastinib
• Design and implement comprehensive training strategies to support product launches, including rare disease and specialty therapeutics
• Develop and deliver sales training programs covering disease state education, product knowledge, selling skills, and digital tools
• Lead instructional design efforts, integrating adult learning principles and innovative modalities (e.g., virtual, in-person, microlearning)
• Manage Learning Management System (LMS) content and ensure seamless delivery and tracking of training initiatives
• Collaborate cross-functionally with Sales, Marketing, Medical Affairs, Market Access, Compliance, and HR to align training with business objectives
• Develop the training plan in integrating new systems, processes, platforms or ways of working for the commercial teams (ex: new CRM features or capabilities)
• Establish performance metrics and feedback loops to measure training effectiveness and field readiness
• Elevate L&D planning by identifying gaps, provide recommendations and implement a plan that will enhance current capabilities for the future
• Oversee vendor relationships and budget planning for external training partners and resources
• Support POA meetings, field communications, and continuous learning initiatives

Director, Commercial Training

Marketing Operations

• Serve as a strategic partner to the bezuclastinib brand team, ensuring Marketing Operations aligns with Cogent Commercial objectives to enhance executional effectiveness.
• Develop and implement a marketing operations strategy aligned with the unique needs of bezuclastinib and its potential three indications.
• Drive continuous improvement in operational processes to support agility, scalability, and compliance.
• Lead budget planning, resource allocation, and vendor oversight to support commercial execution.
• Key commercial lead for the Cogent internal promotional review process (MLR) and manage the end-to-end content approval process for key commercial materials.
• Ensure timely and compliant review of promotional materials, including HCP and patient-facing assets.
• Manage critical systems supporting these processes such as Veeva Vault PromoMats and ensure system optimization for content approval workflows.
• Work with marketing to ensure the execution of complex customer engagement plans into high-performing omnichannel campaigns across HCP, patient, and caregiver audiences.
• Collaborate with analytics teams to integrate insights into campaign design and optimization.
• Ensure systems and platforms readiness to track key data and metrics for campaign effectiveness and measurement.
• Ensure personalization and precision in outreach, leveraging data and segmentation strategies.
• Oversee speaker bureau operations, including nomination, contracting, onboarding, and program logistics.
• Ensure compliance with industry regulations (e.g., FDA, transfer of value) and internal policies.
• Lead execution of congresses, conventions, and field-sponsored events with a focus on ensuring full optimization of congress presence and execution.
• Manage agency selection, onboarding, performance tracking, and contract alignment.
• Establish KPIs and ensure high-quality deliverables that support brand objectives and scientific integrity.
• Develop and deliver training programs for internal stakeholders and agency partners.
• Maintain SOPs and process documentation tailored to the key indications for bezuclastinib marketing operations.

Director / Senior Director, Marketing Operations

• The Senior Director, Payer Accounts is a field-based position responsible for managing a team of Account Directors focused on gaining and maintaining broad coverage and access for Cogent’s products.
• This individual will be responsible for building and maintaining relationships with key stakeholders including regional payers, pharmacy benefit managers (PBMs), MACs and state Medicaid agencies.
• They will collaborate extensively with internal departments and functions to incorporate customer insights into pricing, contracting and market access strategies including Marketing, Sales, and Sales Operations, Patient Services, and Legal.

Senior Director, Payer Accounts

Marketing

• Lead development and execution of U.S. patient marketing strategy for bezuclastinib across three indications (Non-Advanced Systemic Mastocytosis, Advanced Systemic Mastocytosis & Gastro-intestinal Stromal Tumors)
• Shape and deliver compelling patient experiences with emphasis on digital innovation, engagement, and activation
• Design and implement integrated digital ecosystem (websites, search, social, CRM, digital media) to support education, activation, onboarding, and adherence
• Design hyper-personalized modular content plans customized for target audiences
• Develop patient-specific materials for field distribution (branded brochures, treatment initiation kits, doctor discussion tools)
• Establish foundational metrics/KPIs for patient marketing initiatives pre- and post-launch and optimize performance in real-time
• Lead patient segmentation and journey mapping to inform content strategy and audience targeting
• Collaborate with patient advocacy to ensure materials reflect patient needs, voices, and lived experiences
• Lead development and execution of patient advisory boards
• Partner with market access and HUB teams to build messaging and support tools addressing affordability, reimbursement, and treatment continuity
• Consult on development of patient support programs and create resources to enhance engagement and outcomes
• Manage and coordinate agencies of record, external vendors, and internal departments including marketing, analytics, operations, legal, regulatory, medical affairs, compliance, and IT
• Align cross-functional stakeholders to ensure consistency and compliance
• Continuously optimize strategies to improve customer engagement and education of disease and product
• Demonstrate leadership with internal teams to elevate effectiveness of patient-directed programs and share best practices

Senior Director, Patient Marketing

• Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases.
• The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.
• KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells.
• Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
• Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025.
• The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor.
• In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
• Our Team: https://cogent.culturehq.com